Surveillance for Barrett's oesophagus

BMJ

Volumn 322, Issue 7294, 2001, Pages 1124-

  Eksteen, J A ^a   Jankowski, Janusz A ^a   Wild, Christopher Paul ^b   Forman, David ^b   Carr, Richard A ^c   Beales, Ian L P ^d   Playford, R J ^e   Wicks, A C B ^f   Macdonald, C E ^f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SOUTH WARWICKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

^d JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; AGE; ANAMNESIS; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; DRUG USE; ENDOSCOPY; ESOPHAGUS CARCINOMA; GENE CLUSTER; GENE MUTATION; HIGH RISK POPULATION; HUMAN; LETTER; MOLECULAR GENETICS; PRIORITY JOURNAL; SEX RATIO;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK ASSESSMENT;

EID: 85007674406     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.322.7294.1124     Document Type: Letter

References (18)

1. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252–1255. (18 November.)
2. McGarrity TJ. Barrett's oesophagus: the continuing conundrum. BMJ 2000; 321: 1238–1239. (18 November.)
3. Jankowski J, Wright NA, Meltzer S, Triadafilopoulos G, Geboes K, Casson A, et al. Molecular evolution of the metaplasia dysplasia adenocarcinoma sequence in the esophagus (MCS). Am J Pathol 1999; 154: 965–974.
4. Jankowski J, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000; 356: 2079–2085.
5. Jankowski J, Perry I, Harrison RF. Gastro-oesophageal cancer: death at the junction. Understanding changes at the molecular level could lead to screening opportunities. BMJ 2000; 321: 463–464.
6. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252–1255. (18 November.)
7. Kim R, Weissfeld JL, Reynolds JC, Kuller LH. Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiology Biomarkers Prev 1997; 6: 369–377.
8. Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 2000; 92: 1316–1321.
9. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000; 356: 2079–2085.
10. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252–1255. (18 November.)
11. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study. BMJ 2000; 321: 1252–1255. (18 November.)
12. Reid BJ. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 1991; 20: 817–834.
13. Streitz Jr JM, Ellis Jr FH, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998; 93: 911–915.
14. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 1028–1032.
15. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614–621.
16. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 1028–1032.
17. Gross CP, Canto MI, Hixson J, Powe NR. Management of Barrett's esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol 1999; 94: 3440–3447.
18. Nilsson J, Skobe V, Johansson J, Willen R, Johnsson F. Screening for oesophageal adenocarcinoma: an evaluation of a surveillance programme for columnar metaplasia of the oesophagus. Scand J Gastroenterol 2000; 35: 10–16.